Trial Profile
A clinical pharmacological study of SK-0403
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Kowa; Sanwa Kagaku Kenkyusho
- 23 May 2016 New trial record